![]() |
|
|
Vol. 298, Issue 3, 1179-1184, September 2001
Graduate School of Pharmaceutical Sciences (N.M., H.K., Y.S.) and
Department of Pediatrics (T.S.), The University of Tokyo, Tokyo, Japan;
Department of Pharmacology and Toxicology, Kyorin University School of
Medicine, Tokyo, Japan (H.E.); and Core Research for Evolutional
Science and Technology (CREST), Japan Science and Technology
Corporation, Tokyo, Japan (H.K., Y.S.)
Rat organic anion transporter 2 (rOat2) is abundantly expressed in the
liver and localized to the basolateral membrane. A previous
study using the Xenopus laevis oocyte expression system has shown that rOat2 transports organic anions such as salicylate (Sekine et al., 1998) and, in the present study, rOat2 was
characterized using a mammalian expression system. In addition to the
substrates previously shown to be transported by rOat2, three
substrates, indomethacin [IDM, Michaelis-Menten constant
(Km) of 0.37 µM] and nucleoside
derivatives such as 3'-azido-3'-deoxythymidine (AZT,
Km of 26 µM) and 2',3'-dideoxycytidine
(ddC, Km of 3.08 mM), were also identified
for the first time The rank order of rOat2-mediated transport of these
substrates was IDM > salicylate > prostaglandin
E2 > AZT > ddC > p-aminohippurate (PAH). Ketoprofen, indocyanine green
and glibenclamide are potent inhibitors of the uptake of
[14C]salicylate via rOat2 (Ki
of ~12 µM), while diclofenac, benzoate, verapamil, ibuprofen, and
tolbutamide are moderate inhibitors (Ki of
~150 µM). The affinity of PAH, a common substrate for the OAT
family, for rOat2 is low (Ki > 1 mM)
compared with the other members of the OAT family (rOat1 and rOat3).
Salicylate and IDM are also substrates for rOat1, but their affinity
for rOat2 was higher than that for rOat1. The present study shows that
rOat2 is a multispecific transporter and suggests that it may be
involved at least partly, in the hepatic uptake of IDM, salicylate and nucleoside derivatives.
This article has been cited by other articles:
![]() |
T. Nishimura, Y. Seki, K. Sato, T. Chishu, N. Kose, T. Terasaki, Y.-S. Kang, Y. Sai, and E. Nakashima Enhancement of Zidovudine Uptake by Dehydroepiandrosterone Sulfate in Rat Syncytiotrophoblast Cell Line TR-TBT 18d-1 Drug Metab. Dispos., October 1, 2008; 36(10): 2080 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Minematsu, T. Hashimoto, T. Aoki, T. Usui, and H. Kamimura Role of Organic Anion Transporters in the Pharmacokinetics of Zonampanel, an {alpha}-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonist, in Rats Drug Metab. Dispos., August 1, 2008; 36(8): 1496 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Acharya, M. P. O'Connor, J. W. Polli, A. Ayrton, H. Ellens, and J. Bentz Kinetic Identification of Membrane Transporters That Assist P-glycoprotein-Mediated Transport of Digoxin and Loperamide through a Confluent Monolayer of MDCKII-hMDR1 Cells Drug Metab. Dispos., February 1, 2008; 36(2): 452 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mano, T. Usui, and H. Kamimura Comparison of Inhibition Potentials of Drugs against Zidovudine Glucuronidation in Rat Hepatocytes and Liver Microsomes Drug Metab. Dispos., April 1, 2007; 35(4): 602 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ljubojevic, D. Balen, D. Breljak, M. Kusan, N. Anzai, A. Bahn, G. Burckhardt, and I. Sabolic Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones Am J Physiol Renal Physiol, January 1, 2007; 292(1): F361 - F372. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dai, Y. Chen, and W. F. Elmquist Distribution of the Novel Antifolate Pemetrexed to the Brain J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 222 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, Y. Nozaki, H. Endou, and Y. Sugiyama FUNCTIONAL INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 2 (SLC22A7) IN THE HEPATIC UPTAKE OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG KETOPROFEN Drug Metab. Dispos., August 1, 2005; 33(8): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Horita, H. Yamada, J. Inatomi, N. Moriyama, T. Sekine, T. Igarashi, Y. Endo, M. Dasouki, M. Ekim, L. Al-Gazali, et al. Functional Analysis of NBC1 Mutants Associated with Proximal Renal Tubular Acidosis and Ocular Abnormalities J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Gibbs, T. Rashid, and S. A. Thomas Effect of Transport Inhibitors and Additional Anti-HIV Drugs on the Movement of Lamivudine (3TC) across the Guinea Pig Brain Barriers J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1035 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, H. Kusuhara, H. Endou, and Y. Sugiyama Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khamdang, M. Takeda, R. Noshiro, S. Narikawa, A. Enomoto, N. Anzai, P. Piyachaturawat, and H. Endou Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory Drugs J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 534 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Chaturvedi, S. Koul, A. Sekhon, A. Bhandari, M. Menon, and H. K. Koul Oxalate Selectively Activates p38 Mitogen-activated Protein Kinase and c-Jun N-terminal Kinase Signal Transduction Pathways in Renal Epithelial Cells J. Biol. Chem., April 5, 2002; 277(15): 13321 - 13330. [Abstract] [Full Text] [PDF] |
||||